The Central Consumer Protection Authority (CCPA) has issued a directive to Dabur India, requiring the company to stop using '100% pure' or similar claims on the packaging of certain products. This regulatory move comes after an investigation into whether such marketing language accurately reflects the composition of the goods or creates a false impression of absolute purity for the consumer.

While the specific list of affected products is currently being processed by regulatory bodies, the action highlights a broader trend of Indian authorities tightening oversight on health and food labeling. The CCPA’s mandate is part of an effort to ensure that companies provide transparent information, preventing consumers from being misled by marketing buzzwords that may not be supported by the actual manufacturing process or ingredient lists.

There is currently no indication that the products themselves are unsafe or illegal to sell; rather, the dispute centers specifically on the accuracy of the labeling. Dabur has been instructed to revise its packaging to comply with consumer protection standards. The company is expected to phase out the contested claims as it updates its product branding to align with the CCPA’s guidelines. This development serves as a reminder to the fast-moving consumer goods (FMCG) sector that regulatory scrutiny regarding health claims is intensifying in the Indian market.